The effects of centralised and specialised combined pharmacological and psychological intervention compared with decentralised and non-specialised treatment in the early course of severe unipolar and bipolar affective disorders - design of two randomised clinical trials

Trials

Volumn 12, Issue , 2011, Pages

  Kessing, Lars V ^a   Hansen, Hanne V ^a   Christensen, Ellen M ^a   Dam, Henrik ^a   Gluud, Christian ^a   Wetterslev, Jørn ^a  

^a Rigshospitalet   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; BIPOLAR DISORDER; DEPRESSION; FEMALE; HOSPITALIZATION; HUMAN; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; MANIA; MOOD DISORDER; MULTICENTER STUDY; OUTCOME ASSESSMENT; OUTPATIENT; RANDOMIZED CONTROLLED TRIAL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; METHODOLOGY; MULTIMODALITY CANCER THERAPY; PSYCHOLOGICAL ASPECT; PSYCHOTHERAPY; SAMPLE SIZE;

ANTIDEPRESSANT AGENT;

ANTIDEPRESSIVE AGENTS; BIPOLAR DISORDER; COMBINED MODALITY THERAPY; DEPRESSIVE DISORDER; HUMANS; PSYCHOTHERAPY; RESEARCH DESIGN; SAMPLE SIZE; SEVERITY OF ILLNESS INDEX;

EID: 79551511170     PISSN: 17456215     EISSN: 17456215     Source Type: Journal    
DOI: 10.1186/1745-6215-12-32     Document Type: Article

References (90)

1. Kessing LV, Hansen MG, Andersen PK, Angst J. The predictive effect of episodes on the risk of recurrence in depressive and bipolar disorders - a life-long perspective. Acta Psychiatr Scand 2004, 109(5):339-344. 10.1046/j.1600-0447.2003.00266.x, 15049770.
2. Solomon DA, Keller MB, Leon AC, et al. Multiple recurrences of major depressive disorder. Am J Psychiatry 2000, 157(2):229-233. 10.1176/appi.ajp.157.2.229, 10671391.
3. Strakowski SM, Keck PE, Sax KW, McElroy SL, Hawkins JM. Twelve-month outcome of patients with DSM-III-R schizoaffective disorder: comparisons to matched patients with bipolar disorder. Schizophr Res 1999, 35(2):167-174. 10.1016/S0920-9964(98)00119-4, 9988853.
4. Tohen M, Hennen J, Zarate CM, et al. Two-year syndromal and functional recovery in 219 cases of first-episode major affective disorder with psychotic features. Am J Psychiatry 2000, 157(2):220-228. 10.1176/appi.ajp.157.2.220, 10671390.
5. Kessing LV. Cognitive impairment in the euthymic phase of affective disorder. Psychol Med 1998, 28(5):1027-1038. 10.1017/S0033291798006862, 9794010.
6. Torres IJ, Boudreau VG, Yatham LN. Neuropsychological functioning in euthymic bipolar disorder: a meta-analysis. Acta Psychiatr Scand Suppl 2007, (434):17-26. 10.1111/j.1600-0447.2007.01055.x, 17688459.
7. Hasselbalch BJ, Knorr U, Kessing LV. Cognitive impairment in the remitted state of unipolar depressive disorder: A systematic review. Journal of Affective Disorders 2010,
8. Kessing LV, Nilsson FM. Increased risk of developing dementia in patients with major affective disorders compared to patients with other medical illnesses. J Affect Disord 2003, 73(3):261-269. 10.1016/S0165-0327(02)00004-6, 12547295.
9. Ownby RL, Crocco E, Acevedo A, John V, Loewenstein D. Depression and risk for Alzheimer disease: systematic review, meta-analysis, and metaregression analysis. Arch Gen Psychiatry 2006, 63(5):530-538. 10.1001/archpsyc.63.5.530, 16651510.
10. Goodwin GM, Geddes JR. Latest maintenance data on lithium in bipolar disorder. Eur Neuropsychopharmacol 2003, 13(Suppl 2):S51-5-S51-S55.
11. Geddes JR, Carney SM, Davies C, et al. Relapse prevention with antidepressant drug treatment in depressive disorders: a systematic review. Lancet 2003, 361(9358):653-661. 10.1016/S0140-6736(03)12599-8, 12606176.
12. Colom F, Vieta E, Martinez-Aran A, et al. A randomized trial on the efficacy of group psychoeducation in the prophylaxis of recurrences in bipolar patients whose disease is in remission. Arch Gen Psychiatry 2003, 60(4):402-407. 10.1001/archpsyc.60.4.402, 12695318.
13. Huxley NA, Parikh SV, Baldessarini RJ. Effectiveness of psychosocial treatments in bipolar disorder: state of the evidence. Harv Rev Psychiatry 2000, 8(3):126-140.
14. Lam DH, Watkins ER, Hayward P, et al. A randomized controlled study of cognitive therapy for relapse prevention for bipolar affective disorder: outcome of the first year. Arch Gen Psychiatry 2003, 60(2):145-152. 10.1001/archpsyc.60.2.145, 12578431.
15. Maj M, Veltro F, Pirozzi R, Lobrace S, Magliano L. Pattern of recurrence of illness after recovery from an episode of major depression: a prospective study. Am J Psychiatry 1992, 149(6):795-800.
16. Miklowitz DJ, George EL, Richards JA, Simoneau TL, Suddath RL. A randomized study of family-focused psychoeducation and pharmacotherapy in the outpatient management of bipolar disorder. Arch Gen Psychiatry 2003, 60(9):904-912. 10.1001/archpsyc.60.9.904, 12963672.
17. Morriss RK, Faizal MA, Jones AP, Williamson PR, Bolton C, McCarthy JP. Interventions for helping people recognise early signs of recurrence in bipolar disorder. Cochrane Database Syst Rev 2007, (1):CD004854.
18. Paykel ES, Scott J, Teasdale JD, et al. Prevention of relapse in residual depression by cognitive therapy: a controlled trial. Arch Gen Psychiatry 1999, 56(9):829-835. 10.1001/archpsyc.56.9.829, 12884889.
19. Segal Z, Vincent P, Levitt A. Efficacy of combined, sequential and crossover psychotherapy and pharmacotherapy in improving outcomes in depression. J Psychiatry Neurosci 2002, 27(4):281-290. 161662, 12174737.
20. Teasdale JD, Segal ZV, Williams JM, Ridgeway VA, Soulsby JM, Lau MA. Prevention of relapse/recurrence in major depression by mindfulness-based cognitive therapy. J Consult Clin Psychol 2000, 68(4):615-623. 10.1037/0022-006X.68.4.615, 10965637.
21. Solomon DA, Keller MB, Leon AC, et al. Multiple recurrences of major depressive disorder. Am J Psychiatry 2000, 157(2):229-233. 10.1176/appi.ajp.157.2.229, 10671391.
22. Kessing LV, Hansen MG, Andersen PK. Course of illness in depressive and bipolar disorders. Naturalistic study, 1994-1999. Br J Psychiatry 2004, 185:372-377. 10.1192/bjp.185.5.372, 15516544.
23. Kessing LV, Hansen MG, Andersen PK, Angst J. The predictive effect of episodes on the risk of recurrence in depressive and bipolar disorders - a life-long perspective. Acta Psychiatr Scand 2004, 109(5):339-344. 10.1046/j.1600-0447.2003.00266.x, 15049770.
24. Vestergaard P, Schou M. Prospective studies on a lithium cohort. 1. General features. Acta Psychiatr Scand 1988, 78(4):421-426. 10.1111/j.1600-0447.1988.tb06361.x, 3227961.
25. Maj M, Veltro F, Pirozzi R, Lobrace S, Magliano L. Pattern of recurrence of illness after recovery from an episode of major depression: a prospective study. Am J Psychiatry 1992, 149(6):795-800.
26. Melfi CA, Chawla AJ, Croghan TW, Hanna MP, Kennedy S, Sredl K. The effects of adherence to antidepressant treatment guidelines on relapse and recurrence of depression. Arch Gen Psychiatry 1998, 55(12):1128-1132. 10.1001/archpsyc.55.12.1128, 9862557.
27. Demyttenaere K, Adelin A, Patrick M, Walthere D, Katrien D, Michele S. Six-month compliance with antidepressant medication in the treatment of major depressive disorder. Int Clin Psychopharmacol 2008, 23(1):36-42. 10.1097/YIC.0b013e3282f1c1d8, 18090506.
28. Hansen HV, Kessing LV. Adherence to antidepressant treatment. Expert Rev Neurother 2007, 7(1):57-62. 10.1586/14737175.7.1.57, 17187497.
29. Kessing LV, Sondergard L, Kvist K, Andersen PK. Adherence to lithium in naturalistic settings: results from a nationwide pharmacoepidemiological study. Bipolar Disord 2007, 9(7):730-736. 10.1111/j.1399-5618.2007.00405.x, 17988363.
30. varez-Jimenez M, Parker AG, Hetrick SE, McGorry PD, Gleeson JF. Preventing the Second Episode: A Systematic Review and Meta-analysis of Psychosocial and Pharmacological Trials in First-Episode psychosis. Schizophr Bull 2009,
31. Bauer MS, Williford WO, Dawson EE, et al. Principles of effectiveness trials and their implementation in VA Cooperative Study #430: 'Reducing the efficacy-effectiveness gap in bipolar disorder'. J Affec Disord 2001, 67(1-3):61-78.
32. Bauer MS, McBride L, Williford WO, et al. Collaborative care for bipolar disorder: Part II. Impact on clinical outcome, function, and costs. Psychiatr Serv 2006, 57(7):937-945. 10.1176/appi.ps.57.7.937, 16816277.
33. Bauer MS, McBride L, Williford WO, et al. Collaborative care for bipolar disorder: part I. Intervention and implementation in a randomized effectiveness trial. Psychiatr Serv 2006, 57(7):927-936. 10.1176/appi.ps.57.7.927, 16816276.
34. Bauer MS, Biswas K, Kilbourne AM. Enhancing multiyear guideline concordance for bipolar disorder through collaborative care. Am J Psychiatry 2009, 166(11):1244-1250. 10.1176/appi.ajp.2009.09030342, 19797436.
35. Simon GE, Ludman EJ, Bauer MS, Unutzer J, Operskalski B. Long-term effectiveness and cost of a systematic care program for bipolar disorder. Arch Gen Psychiatry 2006, 63(5):500-508. 10.1001/archpsyc.63.5.500, 16651507.
36. Wells K, Sherbourne C, Schoenbaum M, et al. Five-year impact of quality improvement for depression: results of a group-level randomized controlled trial. Arch Gen Psychiatry 2004, 61(4):378-386. 10.1001/archpsyc.61.4.378, 15066896.
37. van Os TW, van den Brink RH, Tiemens BG, Jenner JA, Van der MK, Ormel J. Are effects of depression management training for General Practitioners on patient outcomes mediated by improvements in the process of care?. J Affect Disord 2004, 80(2-3):173-179. 10.1016/S0165-0327(03)00074-0, 15207930.
38. Dietrich AJ, Oxman TE, Williams JW, et al. Re-engineering systems for the treatment of depression in primary care: cluster randomised controlled trial. BMJ 2004, 329(7466):602. 10.1136/bmj.38219.481250.55, 516659, 15345600.
39. Badamgarav E, Weingarten SR, Henning JM, et al. Effectiveness of disease management programs in depression: a systematic review. Am J Psychiatry 2003, 160(12):2080-2090. 10.1176/appi.ajp.160.12.2080, 14638573.
40. Oxman TE, Dietrich AJ, Schulberg HC. The depression care manager and mental health specialist as collaborators within primary care. Am J Geriatr Psychiatry 2003, 11(5):507-516.
41. Von Korff M, Goldberg D. Improving outcomes in depression. Br med J 2001, 323:7319-7949.
42. Berk M, Hallam K, Malhi GS, et al. Evidence and implications for early intervention in bipolar disorder. J Ment Health 2010, 19(2):113-126. 10.3109/09638230903469111, 20433320.
43. Franchini L, Zanardi R, Smeraldi E, Gasperini M. Early onset of lithium prophylaxis as a predictor of good long-term outcome. Eur Arch Psychiatry Clin Neurosci 1999, 249(5):227-230. 10.1007/s004060050091, 10591987.
44. Swann AC, Bowden CL, Calabrese JR, Dilsaver SC, Morris DD. Differential effect of number of previous episodes of affective disorder on response to lithium or divalproex in acute mania. Am J Psychiatry 1999, 156(8):1264-1266.
45. Post RM, Leverich GS, Altshuler LL, et al. An overview of recent findings of the Stanley Foundation Bipolar Network (Part I). Bipolar Disord 2003, 5(5):310-319. 10.1034/j.1399-5618.2003.00051.x, 14525551.
46. Baethge C, Smolka MN, Gruschka P, et al. Does prophylaxis-delay in bipolar disorder influence outcome? Results from a long-term study of 147 patients. Acta Psychiatr Scand 2003, 107(4):260-267. 10.1034/j.1600-0447.2003.02057.x, 12662248.
47. Baldessarini RJ, Tondo L, Hennen J. Treatment-latency and previous episodes: relationships to pretreatment morbidity and response to maintenance treatment in bipolar I and II disorders. Bipolar Disord 2003, 5(3):169-179. 10.1034/j.1399-5618.2003.00030.x, 12780871.
48. Scott J, Paykel E, Morriss R, et al. Cognitive-behavioural therapy for severe and recurrent bipolar disorders: randomised controlled trial. Br J Psychiatry 2006, 188:313-320. 10.1192/bjp.188.4.313, 16582056.
49. Vieta E, Pacchiarotti I, Valenti M, Berk L, Scott J, Colom F. A critical update on psychological interventions for bipolar disorders. Curr Psychiatry Rep 2009, 11(6):494-502. 10.1007/s11920-009-0075-0, 19909673.
50. Lam DH, Burbeck R, Wright K, Pilling S. Psychological therapies in bipolar disorder: the effect of illness history on relapse prevention - a systematic review. Bipolar Disord 2009, 11(5):474-482. 10.1111/j.1399-5618.2009.00724.x, 19624386.
51. Berk M, Hallam K, Malhi GS, et al. Evidence and implications for early intervention in bipolar disorder. J Ment Health 2010, 19(2):113-126. 10.3109/09638230903469111, 20433320.
52. Robinson LJ, Ferrier IN. Evolution of cognitive impairment in bipolar disorder: a systematic review of cross-sectional evidence. Bipolar Disord 2006, 8(2):103-116. 10.1111/j.1399-5618.2006.00277.x, 16542180.
53. Lagace DC, Eisch AJ. Mood-stabilizing drugs: are their neuroprotective aspects clinically relevant?. Psychiatr Clin North Am 2005, 28(2):399-414. 10.1016/j.psc.2005.02.002, 15826739.
54. Fountoulakis KN, Vieta E, Bouras C, et al. A systematic review of existing data on long-term lithium therapy: neuroprotective or neurotoxic?. Int J Neuropsychopharmacol 2008, 11(2):269-287. 10.1017/S1461145707007821, 17506922.
55. Kessing LV, Sondergard L, Forman JL, Andersen PK. Lithium treatment and risk of dementia. Arch Gen Psychiatry 2008, 65(11):1331-1335. 10.1001/archpsyc.65.11.1331, 18981345.
56. Smith EG, Sondergard L, Lopez AG, Andersen PK, Kessing LV. Association between consistent purchase of anticonvulsants or lithium and suicide risk: a longitudinal cohort study from Denmark, 1995-2001. J Affect Disord 2009, 117(3):162-167. 10.1016/j.jad.2009.01.013, 19243837.
57. Kessing LV, Forman JL, Andersen PK. Does lithium protect against dementia?. Bipolar Disord 2010, 12(1):87-94. 10.1111/j.1399-5618.2009.00788.x, 20148870.
58. Warner-Schmidt JL, Duman RS. Hippocampal neurogenesis: opposing effects of stress and antidepressant treatment. Hippocampus 2006, 16(3):239-249. 10.1002/hipo.20156, 16425236.
59. Kessing LV, Sondergard L, Forman JL, Andersen PK. Antidepressants and dementia. J Affect Disord 2009,
60. Salvadore G, Drevets WC, Henter ID, Zarate CA, Manji HK. Early Intervention in Bipolar Disorder, Part I: Clinical and Imaging Findings. Early Interv Psychiatry 2008, 2(3):122-135. 10.1111/j.1751-7893.2008.00071.x, 2613320, 19649152.
61. Hirschfeld RM, Lewis L, Vornik LA. Perceptions and impact of bipolar disorder: how far have we really come? Results of the national depressive and manic-depressive association 2000 survey of individuals with bipolar disorder. J Clin Psychiatry 2003, 64(2):161-174. 10.4088/JCP.v64n0209, 12633125.
62. Zwarenstein M, Treweek S, Gagnier JJ, et al. Improving the reporting of pragmatic trials: an extension of the CONSORT statement. BMJ 2008, 337:a2390. 10.1136/bmj.a2390, 19001484.
63. Kessing LV, Hansen HV, Hougaard E, Hvenegaard A, Albæk J. Preventive outpatient treatment in affective disorders. Results from a Health Technology Assessment (HTA). 2006, 6(9). Copenhagen: National Board of Health, Danish Centre for Evaluation and Health Technology Assessment Danish Health Technology Assessment - Projects funded by Dacehta, 2006. Ref Type: Report., http://www.sst.dk/publ/publ2006/CEMTV/Affektive_lidelser/affektive_lidelser_UK.pdf
64. Dam H, Bendsen BB, Jakobsen K, et al. Variations between psychiatric hospitals in clinical features and treatment of depression - results from a depression database for inpatients in Copenhagen. Ugeskr Laeger 2010, 172:3183-3187.
65. Licht RW, Vestergaard P, Kessing LV, Larsen JK, Thomsen PH. Psychopharmacological treatment with lithium and antiepileptic drugs: suggested guidelines from the Danish Psychiatric Association and the Child and Adolescent Psychiatric Association in Denmark. Acta Psychiatr Scand Suppl 2003, (419):1-22. 10.1034/j.1600-0447.108.s419.1.x, 12974784.
66. National Board of Health DS Reference program for adults with unipolar depression (in Danish: Referenceprogram for unipolar depression hos voksne). 2007, Ref Type: Report, National Board of Health DS.
67. Grunze H, Kasper S, Goodwin G, Bowden C, Moller HJ. The World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the biological treatment of bipolar disorders, part III: maintenance treatment. World J Biol Psychiatry 2004, 5(3):120-135. 10.1080/15622970410029924, 15346536.
68. Grunze H, Kasper S, Goodwin G, et al. World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for biological treatment of bipolar disorders. Part I: Treatment of bipolar depression. World J Biol Psychiatry 2002, 3(3):115-124. 10.3109/15622970209150612, 12478876.
69. Grunze H, Vieta E, Goodwin GM, et al. The World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for the Biological Treatment of Bipolar Disorders: Update 2010 on the treatment of acute bipolar depression. World J Biol Psychiatry 2010, 11(2):81-109. 10.3109/15622970903555881, 20148751.
70. Bauer M, Whybrow PC, Angst J, Versiani M, Möller H-J, . WFSBP Task Force on Treatment Guidelines for Unipolar Depressive Disorders World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for biological treatment of unipolar depressive disorders, Part 2: Maintenance treatment of major depressive disorder and treatment of chronic depressive disorders and subtreshold depressions. World J Biol Psychiatry 2002, 3:69-86. 10.3109/15622970209150605, 12479080, WFSBP Task Force on Treatment Guidelines for Unipolar Depressive Disorders.
71. Bauer M, Whybrow P, Angst J, Versiani M, Moeller HJ, . WFSBP Task Force on Treatment of Unipolar Depressive Disorder World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Unipolar Depressive Disorders, Part 1: Acute and continuation treatment of major depressive disorder. World J Biol Psychiatry 2002, 3:5-43. 10.3109/15622970209150599, 12479086, WFSBP Task Force on Treatment of Unipolar Depressive Disorder.
72. Munk-Jorgensen P, Mortensen PB. The Danish Psychiatric Central Register. Dan Med Bull 1997, 44(1):82-84.
73. World Health Organisation Klassifikation af sygdomme. Systematisk del. International Statistical Classification of Diseases and Health Related Problems. Tenth revision (Danish Edition). 1993, Copenhagen: Munksgaard, Copenhagen, World Health Organisation.
74. Bech P, Olsen LR. [Discovering depression]. Ugeskr Laeger 2001, 163(14):1980-1982.
75. Bech P, Rasmussen NA, Olsen LR, Noerholm V, Abildgaard W. The sensitivity and specificity of the Major Depression Inventory, using the Present State Examination as the index of diagnostic validity. J Affect Disord 2001, 66(2-3):159-164. 10.1016/S0165-0327(00)00309-8, 11578668.
76. Olsen LR, Jensen DV, Noerholm V, Martiny K, Bech P. The internal and external validity of the Major Depression Inventory in measuring severity of depressive states. Psychol Med 2003, 33(2):351-356. 10.1017/S0033291702006724, 12622314.
77. Hirschfeld RM, Williams JB, Spitzer RL, et al. Development and validation of a screening instrument for bipolar spectrum disorder: the Mood Disorder Questionnaire. Am J Psychiatry 2000, 157(11):1873-1875. 10.1176/appi.ajp.157.11.1873, 11058490.
78. Hirschfeld RM, Holzer C, Calabrese JR, et al. Validity of the mood disorder questionnaire: a general population study. Am J Psychiatry 2003, 160(1):178-180. 10.1176/appi.ajp.160.1.178, 12505821.
79. Demyttenaere K, Enzlin P, Dewe W, et al. Compliance with antidepressants in a primary care setting, 2: the influence of gender and type of impairment. J Clin Psychiatry 2001, 62(Suppl 22):34-7. 34-37.
80. Kessing LV, Hansen HV, Demyttenaere K, Bech P. Depressive and bipolar disorders: patients' attitudes and beliefs towards depression and antidepressants. Psychol Med 2005, 35(8):1205-1213. 10.1017/S0033291705004605, 16116946.
81. Bech P, Olsen LR, Kjoller M, Rasmussen NK. Measuring well-being rather than the absence of distress symptoms: a comparison of the SF-36 Mental Health subscale and the WHO-Five Well-Being Scale. Int J Methods Psychiatr Res 2003, 12(2):85-91. 10.1002/mpr.145, 12830302.
82. Bech P. Health-related quality of life measurements in the assessment of pain clinic results. Acta Anaesthesiol Scand 1999, 43(9):893-896. 10.1034/j.1399-6576.1999.430906.x, 10522736.
83. Kessing LV, Hansen HV, Ruggeri M, Bech P. Satisfaction with treatment among patients with depressive and bipolar disorders. Soc Psychiatry Psychiatr Epidemiol 2006, 41(2):148-155. 10.1007/s00127-005-0012-4, 16456641.
84. Juel K, Helweg-Larsen K. The Danish registers of causes of death. Dan Med Bull 1999, 46:354-357.
85. Department of Psychiatric Demography AD Annual report 2001. 2002, Ref Type: Report, Department of Psychiatric Demography AD.
86. Colom F, Vieta E, Martinez-Aran A, et al. A randomized trial on the efficacy of group psychoeducation in the prophylaxis of recurrences in bipolar patients whose disease is in remission. Arch Gen Psychiatry 2003, 60(4):402-407. 10.1001/archpsyc.60.4.402, 12695318.
87. Danish National Board of Health L Medicinal Product Statistics. 2002, Ref Type: Electronic Citation, Danish National Board of Health L., http://www.laegemiddelstyrelsen.dk
88. Kessing L. Validity of diagnoses and other clinical register data in patients with affective disorder. Eur Psychiatry 1998, 13(8):392-398. 10.1016/S0924-9338(99)80685-3, 19698654.
89. Bock C, Bukh JD, Vinberg M, Gether U, Kessing LV. Validity of the diagnosis of a single depressive episode in a case register. Clin Pract Epidemiol Ment Health 2009, 5(4):4. 10.1186/1745-0179-5-4, 2660321, 19216741.
90. Burns T. End of the road for treatment-as-usual studies?. Br J Psychiatry 2009, 195(1):5-6. 10.1192/bjp.bp.108.062968, 19567887.